A carregar...

A Comparative Pharmacokinetics Study of the Anti-Parkinsonian Drug Pramipexole

The present study aimed to compare pharmacokinetic parameters of two pramipexole 0.25 mg formulations in order to show bioequivalence. The study was conducted in a randomized, open-label, two-period, two-sequence, and crossover design, involving 23 healthy volunteers. One of the 0.25 mg formulations...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Sci Pharm
Main Authors: Putri, Ratih S. I., Setiawati, Effi, Aziswan, Syifa A., Ong, Fenny, Tjandrawinata, Raymond R., Susanto, Liana W.
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2016
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5198030/
https://ncbi.nlm.nih.gov/pubmed/27869754
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/scipharm84040715
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!